Preliminary treatment results of pegylated interferon alpha 2b and ribavirin in liver transplant recipients with recurrent hepatitis C virus nonresponsive to interferon alpha2b and ribavirin

被引：0
|
作者：
Neff, GW [1 ]
Montalbano, M [1 ]
Ozden, N [1 ]
Muslu, H [1 ]
Lee, YM [1 ]
Safdar, K [1 ]
Morrero, R [1 ]
Nery, J [1 ]
Weppler, D [1 ]
Madariaga, J [1 ]
Levi, D [1 ]
Nashida, S [1 ]
Kato, T [1 ]
Schiff, E [1 ]
Tzakis, A [1 ]
机构：
[1] Univ Miami, Coral Gables, FL 33124 USA
来源：
JOURNAL OF HEPATOLOGY | 2003年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
552
引用
收藏
页码：160 / 160
页数：1
相关论文
共 50 条
  • [1] Preliminary treatment results of liver transplant recipients with recurrent hepatitis C virus nonresponsive to interferon alpha2B and ribavirin using combination pegylated interferon alpha 2B with ribavirin.
    Neff, GW
    Montalbano, M
    Lee, YM
    Slapak, G
    Safdar, K
    Morrero, R
    Nery, J
    Weppler, D
    Demodina, M
    Schiff, E
    Tzakis, A
    [J]. HEPATOLOGY, 2002, 36 (04) : 183A - 183A
  • [2] Pegylated interferon α-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C
    Ross, AS
    Bhan, AK
    Pascual, M
    Thiim, M
    Cosimi, AB
    Chung, RT
    [J]. CLINICAL TRANSPLANTATION, 2004, 18 (02) : 166 - 173
  • [3] A randomized prospective clinical trial comparing pegylated interferon alpha 2a/ribavirin versus pegylated interferon alpha 2b/ribavirin in the treatment of Chronic Hepatitis C
    Sinha, S
    Gulur, P
    Patel, V
    Hage-Nassar, G
    Tenner, S
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S77 - S78
  • [4] Treatment with combination peginterferon alfa-2b and ribavirin of recurrent hepatitis C in liver transplant recipients nonresponsive to interferon alfa-2b and ribavirin
    Samanta, A
    Mandalapu, A
    Fisher, A
    Wilson, D
    de la Torre, A
    Klein, KM
    Koneru, B
    [J]. GASTROENTEROLOGY, 2005, 128 (04) : A455 - A456
  • [5] Combination of interferon alfa 2b and ribavirin in liver transplant recipients with histologic recurrent hepatitis C
    Firpi, RJ
    Nelson, DR
    Soldevila, C
    Abdelmalek, MF
    Reed, A
    Hemming, A
    Howard, R
    Van der Werk, W
    Lauwers, G
    Davis, GL
    [J]. GASTROENTEROLOGY, 2001, 120 (05) : A93 - A93
  • [6] Treatment of acute hepatitis C with pegylated interferon alpha-2b and ribavirin
    Capozza, TA
    Brann, OS
    Coyle, WJ
    Schindler, WR
    BeMiller, TA
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S188 - S188
  • [7] Interferon Alpha 2b in Combination with Ribavirin as a Treatment for Chronic Hepatitis C
    Mandokhel, Sherbet Khan
    Aziz-U-Rehman
    Khan, Mohammad Saleem
    Azeemullah
    [J]. PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2011, 5 (01): : 168 - 171
  • [8] Cost effectiveness of pegylated interferon alpha 2b and ribavirin combination in chronic hepatitis C
    Poynard, T
    [J]. GUT, 2003, 52 (10) : 1532 - 1532
  • [9] Treatment of recurrent hepatitis C infection after liver transplantation: Randomized controlled trial of peg interferon alpha 2b and ribavirin vs. peg interferon alpha 2b, ribavirin and amantadine
    Nair, S
    Lipscomb, J
    Malloy, H
    Loss, G
    Cohen, A
    Eason, J
    [J]. GASTROENTEROLOGY, 2004, 126 (04) : A699 - A699
  • [10] Triple combination of pegylated interferon alpha 2b, ribavirin and amantadine for treatment of chronic hepatitis
    Younossi, ZM
    McCullough, AJ
    Barnes, DS
    Post, A
    Ong, JP
    Mullen, KD
    Carey, WD
    O'Shea, R
    Levinthal, G
    Gramlich, T
    Martin, LM
    Bringman, D
    Tavill, A
    Ferguson, R
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A781 - A781
12345